For research teamsHelp me find a study
Study directory

Depression studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
6115studies shown
Showing 4,777-4,788 of 6,115
Device study icon
CompletedNCT04785456

rTMS for Suicide prevention in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Toronto
Why is this study shown?

This study includes Depression among several conditions.

Suicidality, Depression, ...DeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Suicidality, Depression, ...
View study
Other study type icon
CompletedNCT01269710

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
Why is this study shown?

This study includes Depression among several conditions.

Schizophrenia, Depression, ...ObservationalA study where researchers collect information without assigning a treatment.From 3 Years to 19 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia, Depression, ...
View study
Drug study icon
TerminatedNCT00182533

Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Hamilton
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, Depression, ...DrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
Canada
Sponsor
Hamilton Health Sciences Corporation
Condition
Anxiety, Depression, ...
View study
Drug study icon
CompletedNCT05859698

Effectiveness of valbenazine in adults with tardive dyskinesia

This study is completed in the United States. It focuses on adults with tardive dyskinesia.

Multiple locations, including Bryant
Why is this study shown?

This study includes Depression among several conditions.

Schizophrenia, Depression, ...DrugOver 18 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia, Depression, ...
View study
Behavioral study icon
CompletedNCT02400736

Supported Employment in Patient Aligned Care Teams

This summary needs review. Please check the official study record and contact the research team for details.

In Tuscaloosa
Why is this study shown?

This study includes Depression among several conditions.

Addiction, Depression, ...BehavioralOver 19 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Addiction, Depression, ...
View study
Behavioral study icon
CompletedNCT02308956

Task Sharing for the Care of Severe Mental Disorders in a Low-income Country

This summary needs review. Please check the official study record and contact the research team for details.

In Butajīra
Why is this study shown?

This study includes Depression among several conditions.

Schizophrenia, Depression, ...BehavioralOver 25 Years
Countries
Ethiopia
Sponsor
University of Cape Town
Condition
Schizophrenia, Depression, ...
View study
Behavioral study icon
CompletedNCT03143634

The Modular Protocol for Mental Health (MPMH)

This summary needs review. Please check the official study record and contact the research team for details.

In Cambridge
Why is this study shown?

This study includes Depression among several conditions.

Anxiety, Depression, ...BehavioralFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Medical Research Council Cognition and Brain Sciences Unit
Condition
Anxiety, Depression, ...
View study
Drug study icon
CompletedNCT00001146

Omega-3 Fatty Acids in the Treatment of Bipolarity: A study

This study is completed in the United States. It focuses on Bipolarity.

In Bethesda
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedEUCTR 2008-007483-42

A 24-Week, Flexible-Dose, Open-label Extension Study of Lurasidone for the Treatment of Bipolar I Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
France, Czechia, Germany, ...
Sponsor
Sunovion Pharmaceuticals Inc.
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedEUCTR 2008-007457-13

A Randomized, 6-Week, Double-Blind, Placebo-controlled, Fixed-Flexible-Dose, Parallel-Group Study of Lurasidone in the Treatment of Bipolar I Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedEUCTR 2008-007482-23

A Randomized, 6-Week, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
France, Czechia, Germany
Sponsor
Sunovion Pharmaceuticals, Inc.
Condition
Bipolarity, Depression
View study
Drug study icon
CompletedEUCTR 2010-019778-34

A RANDOMIZED, 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, FLEXIBLE-DOSE, PARALLEL-GROUP STUDY OF LURASIDONE ADJUNCTIVE TO LITHIUM OR DIVALPROEX FOR THE TREATMENT OF BIPOLAR I DEPRESSION IN SUBJECTS ...

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Czech Republic
Why is this study shown?

This study includes Depression among several conditions.

Bipolarity, DepressionDrug
Countries
Czechia, Lithuania, Slovakia
Sponsor
Sunovion, Inc.
Condition
Bipolarity, Depression
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.